Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinomaTakeshi Terashima, Makoto Yamamoto, Tadashi Toyama, et al.
Cell Host & Microbe|April 12, 2019
Induction of Selenoprotein P mRNA during Hepatitis C Virus Infection Inhibits RIG-I-Mediated Antiviral ImmunityKazuhisa Murai, Masao Honda, Takayoshi Shirasaki, et al.
Scientific Reports|January 23, 2020
Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in miceTomoki Nishikawa, Naoto Nagata, Tetsuro Shimakami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 16, 2020
Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinomaTakeshi Terashima, Tatsuya Yamashita, Noboru Takata, et al.
Plos One|May 23, 2024
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapyMiyabi Miura, Michiko Nishino, Kazunori Kawaguchi, et al.
Hepatology Communications|April 15, 2024
Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitisJunyan Lyu, Hikari Okada, Hajime Sunagozaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 22, 2026
Potential Role of Liver Transplantation for Child-Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan-A Retrospective Single-Center StudyAkihiro Seki, Tomoyoshi Chiba, Shintaro Yagi, et al.
Life (Basel, Switzerland)|September 9, 2020
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with CirrhosisTsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, et al.
Gastro Hep Advances|October 27, 2025
Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A AntibodiesGen Sugiyama, Kouki Nio, Hikari Okada, et al.
Viruses|February 27, 2026
Development of a Novel Human Hepatoma Cell Line Supporting the Replication of a Recombinant HBV Genome with a Reporter GeneShotaro Kawase, Tetsuro Shimakami, Kazuyuki Kuroki, et al.
Pageof 12